Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents

Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents

US Patent 11261210 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinat2024
Method for controlling an SCR catalytic converter2022
Method for controlling an SCR catalytic converter2021
Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels an2020
Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels an2020
Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels an2020
Method for operating an SCR catalytic converter system which has a first SCR cat2020
Determining an ammonia mass flow between two SCR catalytic converters2019
Method for operating an SCR catalyic converter provided for the aftertreatment o2015
Polyol modified aminoglycoside-lipid conjugates2015
Hydrophobically enhanced aminoglycosides2014
Procedure for metering a reagent and device for implementing the procedure2013